{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:15:16Z","timestamp":1769764516080,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.endinu.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T17:49:20Z","timestamp":1541094560000},"page":"312-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rendimiento de las metanefrinas libres plasm\u00e1ticas en el diagn\u00f3stico de los feocromocitomas y paragangliomas en la poblaci\u00f3n asturiana"],"prefix":"10.1016","volume":"66","author":[{"given":"Eduardo","family":"Mart\u00ednez-Morillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Vald\u00e9s Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Eguia \u00c1ngeles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Fern\u00e1ndez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Prieto Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco V.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2018.08.009_bib0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1575-0922(08)70669-7","article-title":"Pheochromocytoma: Diagnostic and therapeutic update","volume":"55","author":"Oleaga","year":"2008","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endinu.2018.08.009_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","article-title":"Update on modern management of pheochromocytoma and paraganglioma","volume":"32","author":"Lenders","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.endinu.2018.08.009_bib0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0042-100911","article-title":"Clinical and pathological characteristics of hypertensive and normotensive adrenal pheochromocytomas","volume":"124","author":"Lu","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.endinu.2018.08.009_bib0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ancard.2016.04.016","article-title":"Causes of secondary hypertension in the young population: A monocentric study","volume":"65","author":"Noilhan","year":"2016","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.endinu.2018.08.009_bib0170","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: A multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2018.08.009_bib0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas","volume":"92","author":"Timmers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2018.08.009_bib0180","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","author":"Haissaguerre","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2018.08.009_bib0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/enr-2017-0018","article-title":"Pheochromocytoma, diagnosis and treatment: Review of the literature","volume":"51","author":"Farrugia","year":"2017","journal-title":"Endocr Regul"},{"key":"10.1016\/j.endinu.2018.08.009_bib0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1445-5994.2000.tb04358.x","article-title":"Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland","volume":"30","author":"McNeil","year":"2000","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.endinu.2018.08.009_bib0195","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: Why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endinu.2018.08.009_bib0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.endinu.2018.08.009_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj.EJ15-0404","article-title":"Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan","volume":"63","author":"Tabuchi","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.endinu.2018.08.009_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.endinu.2018.08.009_bib0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-123-2-199507150-00004","article-title":"Plasma metanephrines in the diagnosis of pheochromocytoma","volume":"123","author":"Lenders","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endinu.2018.08.009_bib0220","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/archinte.160.19.2957","article-title":"Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma","volume":"160","author":"Raber","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.endinu.2018.08.009_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2002.tb04410.x","article-title":"New advances in the biochemical diagnosis of pheochromocytoma: Moving beyond catecholamines","volume":"970","author":"Lenders","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.endinu.2018.08.009_bib0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365513.2011.622410","article-title":"Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma","volume":"71","author":"Christensen","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.endinu.2018.08.009_bib0235","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.EJ13-0277","article-title":"Plasma free metanephrines in the diagnosis of pheochromocytoma: Diagnostic accuracy and strategies for japanese patients","volume":"61","author":"Tanaka","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.endinu.2018.08.009_bib0240","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2018.08.009_bib0245","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2007.04.012","article-title":"Pheochromocytoma: Advances in genetics, diagnosis, localization, and treatment","volume":"21","author":"Mittendorf","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.endinu.2018.08.009_bib0250","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0025-6196(11)62118-6","article-title":"Pheochromocytoma in a patient with end-stage renal disease","volume":"76","author":"Godfrey","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.endinu.2018.08.009_bib0255","unstructured":"CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved Guideline - Third Edition. CLSI document EP28-A3c (2008)."},{"key":"10.1016\/j.endinu.2018.08.009_bib0260","series-title":"Biological variation: From principles to practice","author":"Fraser","year":"2001"},{"key":"10.1016\/j.endinu.2018.08.009_bib0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00365510410004885","article-title":"The reference change value: A proposal to interpret laboratory reports in serial testing based on biological variation","volume":"64","author":"Ricos","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.endinu.2018.08.009_bib0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1590\/2359-3997000000299","article-title":"The clinical genetics of phaeochromocytoma and paraganglioma","volume":"61","author":"Kavinga Gunawardane","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.endinu.2018.08.009_bib0275","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0004563216646395","article-title":"Screening for phaeochromocytoma and paraganglioma: Impact of using supine reference intervals for plasma metanephrines with samples collected from fasted\/seated patients","volume":"54","author":"Casey","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.endinu.2018.08.009_bib0280","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.endinu.2018.08.009_bib0285","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: A systematic review","volume":"56","author":"Darr","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.endinu.2018.08.009_bib0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","author":"Eisenhofer","year":"2013","journal-title":"Ann Clin Biochem"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418302143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418302143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T15:12:25Z","timestamp":1562080345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016418302143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2530016418302143"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2018.08.009","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rendimiento de las metanefrinas libres plasm\u00e1ticas en el diagn\u00f3stico de los feocromocitomas y paragangliomas en la poblaci\u00f3n asturiana","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}